HBK Investments’s AbbVie ABBV Stock Holding History

HBK Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,371	Closed	-$209K	–	524
2022 Q1	$222K	Sell	1,371 -9,727	-88%	-$1.41M	﹤0.01%	534
2021 Q4	$1.5M	Buy	11,098 +3,827	+53%	+$452K	0.01%	447
2021 Q3	$784K	Buy	+7,271	New	+$831K	﹤0.01%	525
2020 Q4	–	Sell	-12,923	Closed	-$1.24M	–	681
2020 Q3	$1.13M	Buy	+12,923	New	+$1.22M	0.01%	427
2019 Q3	–	Sell	-8,448	Closed	-$614K	–	615
2019 Q2	$614K	Sell	8,448 -39,833	-83%	-$3.13M	0.01%	476
2019 Q1	$3.89M	Buy	+48,281	New	+$3.95M	0.04%	379
2018 Q3	–	Sell	-331,500	Closed	-$31.4M	–	1152
2018 Q2	$30.7M	Buy	331,500 +293,019	+761%	+$28.6M	0.2%	56
2018 Q1	$3.64M	Sell	38,481 -149,619	-80%	-$16.4M	0.03%	343
2017 Q4	$18.2M	Buy	188,100 +84,800	+82%	+$7.99M	0.14%	86
2017 Q3	$9.18M	Buy	+103,300	New	+$7.86M	0.06%	175
2016 Q4	–	Sell	-422,600	Closed	-$26.7M	–	707
2016 Q3	$26.7M	Buy	422,600 +67,122	+19%	+$4.35M	0.24%	73
2016 Q2	$22M	Buy	355,478 +42,078	+13%	+$2.56M	0.16%	80
2016 Q1	$17.9M	Buy	313,400 +209,300	+201%	+$11.7M	0.17%	85
2015 Q4	$6.17M	Buy	+104,100	New	+$6M	0.06%	183

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HBK Investments's ABBV Position: Q2 2022 in Review

HBK Investments sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 1,371 shares — an estimated $209K sold.

HBK Investments first reported a position in ABBV in Q4 2015 and held it in 14 quarters. The position peaked at $30.7M in Q2 2018. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

HBK Investments reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
HBK Investments sold 1,371 AbbVie shares in Q2 2022, an estimated $209K.
HBK Investments first reported a position in AbbVie in Q4 2015 and held it in 14 quarters.
HBK Investments's AbbVie position peaked at $30.7M in Q2 2018.
3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on HBK Investments's 13F filing for Q2 2022, filed 15 Aug 2022.